Herpes Genitalis: all 70 studies
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-VaccinationEnrolling by invitationNCT07330440Phase 1
- Treating Genital Herpes Infection to Reduce Racial Disparities in the Risk of Severe Maternal MorbidityRecruitingNCT05429346
- Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital HerpesNot yet recruitingNCT04979975Phase 2
- A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital HerpesCompletedNCT06033261Phase 1/2Results posted
- A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital HerpesCompletedNCT05298254Phase 1/2Results posted
- Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionTerminatedNCT03146403Phase 2Results posted
- The VIBLOK SAfety and perFormancE TrialCompletedNCT03080961Not applicableResults posted
- Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital HerpesCompletedNCT01687595Phase 2Results posted
- Safety and Efficacy Comparator Trial of a New Drug Against Genital HerpesTerminatedNCT01658826Phase 2Results posted
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT01346475Phase 4Results posted
- Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital HerpesCompletedNCT01281007Phase 3Results posted
- GUD Clinical and Virologic Response to Acyclovir in HIV Negative African WomenCompletedNCT00808405Not applicableResults posted
- A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 ReactivationCompletedNCT00723229Phase 4Results posted
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4Results posted
- Effect of HSV-2 Suppressive Therapy on Sexual BehaviorTerminatedNCT00495716Phase 4Results posted
- Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black PatientsCompletedNCT00477334Phase 4Results posted
- Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in UgandaCompletedNCT00405821Phase 2Results posted
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT00362297Phase 4Results posted
- Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesCompletedNCT00306787Phase 3Results posted
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4Results posted
- A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.CompletedNCT00158860Phase 4Results posted
- VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.CompletedNCT00116844Phase 4Results posted
- A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesCompletedNCT06698575Phase 1
- A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital HerpesCompletedNCT06385327Phase 1
- Knowledge of Young Adults About Genital HerpesStatus unknownNCT05675228
- A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic DiseaseCompletedNCT05500053
- A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes LesionsActive, not recruitingNCT05432583Phase 1
- An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex Virus-2 (HSV-2) in Patients ≥ 18 Years of Age in the United States and Europe.CompletedNCT04950712
- UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the GenitalsStatus unknownNCT04714060Phase 2
- Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer KagocelCompletedNCT04664127
- NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2WithdrawnNCT04294030
- Study of 2LHERP® in Genital Herpes InfectionsTerminatedNCT04235322Phase 4
- Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2TerminatedNCT04222985Phase 1
- Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South AfricaCompletedNCT04205721Not applicable
- Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 InfectionCompletedNCT04165122Phase 2
- Safety and Efficacy of Laser Therapy in GynaecologyStatus unknownNCT04073082
- Melatonin Effects on Genital Herpes in Brazilian WomenCompletedNCT03831165Phase 4
- A Phase 2 Trial to Evaluate the Safety and Efficacy of UB-621Status unknownNCT03595995Phase 2
- Long-term Follow-up of GEN-003-002 Subjects for Efficacy and ImmunogenicityCompletedNCT02910284
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodCompletedNCT02852876Phase 1
- Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA VaccineCompletedNCT02837575Phase 2
- Evaluating New Formulation of Therapeutic HSV-2 VaccineCompletedNCT02515175Phase 2
- Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes InfectionCompletedNCT01915212Phase 1
- A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital HerpesTerminatedNCT01765114Phase 2
- Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)CompletedNCT01390805
- Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital HerpesCompletedNCT01154543
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable
- Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2CompletedNCT01112956
- Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?CompletedNCT00860977Phase 3
- HSV-2 Shedding Resolution After Acyclovir TreatmentCompletedNCT00495573
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNCT00486200Phase 2
- HSV Seroprevalence and Diagnosis of Genital Herpes in Pregnant WomenCompletedNCT00291044
- Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV InfectionCompletedNCT00262106Phase 3
- Trial Evaluating Safety, Tolerability and Immune Response of AG-707CompletedNCT00231049Phase 1
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
- Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
- Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedNCT00171990Phase 3
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
- Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)CompletedNCT00158483Phase 2
- A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedNCT00129818Phase 4
- Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the CommunityStatus unknownNCT00124878Phase 3
- Effect of Male Circumcision on HIV Incidence (ANRS 1265)TerminatedNCT00122525Phase 3
- A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
- A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
- HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, PeruCompletedNCT00023582
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsStatus unknownNCT00005663Phase 3
- The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsCompletedNCT00002404Not applicable
- A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsCompletedNCT00002084Not applicable
- A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected PatientsCompletedNCT00002000Not applicable